Remove 2002 Remove Digital Health Remove Life Science
article thumbnail

Flinn Foundation-Sponsored Study Identifies Three Bioscience Growth Areas to Advance Innovation and Economic Growth in Greater Phoenix

Digital Health Global

Digital health, weartech and medtech, including wearable electronic devices, telehealth, disease detection and remote monitoring. The report was commissioned by the Flinn Foundation , which in 2002 launched Arizona’s Bioscience Roadmap—the state’s long-term strategic plan to guide the progress of the biosciences.

article thumbnail

Amino Health Secures $80 Million in Financing to Accelerate Growth and Product Innovation

Healthcare IT Today

In the face of declining digital health investment, this funding underscores the success of Amino Health’s proven model and enables the company to scale its technology and continue its strong growth trajectory. Since 2002, Oxford has originated approximately $10 billion in loans.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Amino Health Secures $80 Million in Financing to Accelerate Growth and Product Innovation

Digital Health Global

In the face of declining digital health investment, this funding underscores the success of Amino Health’s proven model and enables the company to scale its technology and continue its strong growth trajectory. Since 2002, Oxford has originated approximately $10 billion in loans. To learn more, visit amino.com.

article thumbnail

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

Lloyd Price

In the 2002 Hollywood blockbuster film Minority Report, Tom Cruise’s character merely had to nod or concentrate his gaze to unlock screens of data to help him navigate a danger-laden futuristic life. 2020), leaving little doubt that virtual health and digital platforms will transform healthcare in the coming years.’

article thumbnail

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

AscellaHealth is a Global Specialty Pharmacy and Healthcare Services Organization, which through a wide range of available capabilities and services benefit all industry stakeholders; patients, life sciences manufacturers or intellectual property holders (Nymox) payers and providers. Randall Lanham, Esq.